РОЛЬ МАГНИТНО-РЕЗОНАНСНОЙ ТОМОГРАФИИ МОЛОЧНЫХ ЖЕЛЕЗ В ПЛАНИРОВАНИИ ОРГАНОСОХРАНЯЮЩИХ ОПЕРАЦИЙ ПРИ РАКЕ МОЛОЧНОЙ ЖЕЛЕЗЫ
https://doi.org/10.20862/0042-4676-2016-97-6-373-381
Аннотация
Об авторах
О. С. Пучкова
ФГАУ «Лечебно-реабилитационный центр» Минздрава России,
Иваньковское ш., 3, Москва, 125367, Российская Федерация
Россия
врач-рентгенолог
Россия
врач-рентгенолог
В. Е. Синицын
ФГАУ «Лечебно-реабилитационный центр» Минздрава России,
Иваньковское ш., 3, Москва, 125367, Российская Федерация
Россия
д. м. н., профессор, руководитель Центра лучевой диагностики ЛРЦ
Россия
д. м. н., профессор, руководитель Центра лучевой диагностики ЛРЦ
Е. А. Мершина
ФГАУ «Лечебно-реабилитационный центр» Минздрава России,
Иваньковское ш., 3, Москва, 125367, Российская Федерация
Россия
к. м. н., заведующая отделением функциональных методов лучевой диагностики
Россия
к. м. н., заведующая отделением функциональных методов лучевой диагностики
Список литературы
1. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2013 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена; 2015. [Kaprin A.D., Starinskiy V.V., Petrova G.V. Malignant tumors in Russia in 2013 year (Morbidity and Mortality). Moscow: P.A. Gertsen MNIOI; 2015 (in Russ.).]
2. Veronesi U., Cascinelli N., Mariani L. et al. Twenty-year follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer. N. Engl. J. Med. 2002; 347: 1227–32.
3. Berg W.A., Gutierrez L., Ness Aiver M.S. et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in the preoperative assessment of breast cancer. Radiology. 2004; 233: 830–49.
4. Damadian R. Tumor detection by Nuclear Magnetic Resonance. Science. 1971; 171: 1151–3.
5. Dixon J.M., Anderson T.J., Page D.L., Lee D., Duffy S.W. Infiltrating lobular carcinoma of the breast. Histopathology. 1982; 6: 149–61.
6. Holland R., Solke H., Veling S.H. et al. Histological multifocality of T1s, T1-2 breast carcinomas: implications for clinical trials of breastconserving surgery. Cancer. 1985; 56: 979–90.
7. Hata T., Takahashi H., Watanabe K. et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J. Am. Coll. Surg. 2004; 198: 190–7.
8. Frahm J., Haas A., Matthaei D. Rapid Three-dimentional NMR Imaging Using FLASH Technique. J. Comput. Assist. Tomogr. 1986; 10: 363–8.
9. Mann R.M., Hoogeveen Y.L., Blickmann J.G., Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res. Treat. 2008; 107: 1–14.
10. Peters N.H., van Esser S., van den Bosch M.A. et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET-randomized controlled trial. Eur. J. Cancer. 2011; 47: 879–86.
11. Sung J.S., Li J., Da Costa G. et al. Preoperative breast MRI for earlystage breast cancer: effect on surgical and long-term outcomes. AJR. 2014; 202: 1376–82.
12. Warner E., Causer P.A., Wong J.W.N. et al. Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study. Breast J. 2011; 17: 9–17.
13. Tabar L., Tot T., Peter B.D. Ductal adenocarcinoma of the breast (DAB). III, Part 1. Hong Kong: C&C Offset Printing Co.; 2014.
14. Tabar L., Dean P.B., Chen S.L. et al. Invasive lobular carcinoma of the breast: the use of radiological appearance to classify timor subtypes for better prediction of long term outcome. J. Clin. Exp. Pathol. 2014; 4: 4.
15. Tabar L., Tot T., Peter B.D. Breast cancer: the art and science of early detection with mammography. Stuttgart: Thieme International; 2005.
16. Mann R.M., Loo C.E., Wobbes T. et al. The impact of preoperative breast MR on the re-excision rate in invasive lobular carcinoma. Breast Cancer Res. Treat. 2010; 119: 415–22.
17. Obdeijn I., Tilanus-Linthorst M., Spronk S. et al. Preoperative breast MRI can reduce the rate of tumorpositive resection margins and reoperations in patients undergoing breast-conserving surgery. AJR. 2013; 200: 304–10.
18. Parsyan A., Alqahtani A., Mesurolle B., Meterissian S. Impact of preoperative breast MRI on surgical decision making and clinical outcomes: a systematic review. World J. Surg. 2013; 37 (9): 2134–9.
19. Gonzalez V., Sandelin K., Karlsson A. et al. Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study. World J. Surg. 2014; 38 (7): 1685–93. DOI: 10.1007/s00268- 014-2605-0.
20. Liu Q., Liu Y., Xu L. et al. Multicenter prospective study of magnetic resonance imaging prior to breast-conserving surgery for breast cancer. Chin. Med. J. (Engl). 2014; 127 (13): 2401–6.
21. Siponen E., Hukkinen K., Heikkila P. et al. Surgical treatment in Paget’s disease of the breast. Am. J. Surg. 2010; 200: 241–6.
22. Tabar L., Tot T., Peter B.D. Ductal adenocarcinoma of the breast (DAB). VI, Part 4. Hong Kong: C&C Offset Printing Co., 2015.
23. Любченко Л.Н., Батенева Е.И. Медико-генетическое консультирование и ДНК-диагностика при наследственной предрасположенности к раку молочной железы и раку яичников. М.: ИГ РОНЦ; 2014. [Lyubchenko L.N., Bateneva E.I. Medical-genetic and DNKdiagnostic in patients with hereditary breast and ovarian cancer. Moscow: IG RONTS; 2014 (in Russ.).]
24. Sardanelli F., Podo F., D’Agnolo G., Verdecchia A., Santaquilani M. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology. 2007; 242: 698–715.
25. Rogozinskaya-Szczepka J., UtrackaHutka B. et al. BRCA 1 and BRCA 2 mutations as prognostic factors in bilateral breast cancer patients. Ann. Oncol. 2004; 15: 1373–6.
26. Бит-Сава Е.М. Наследственные характеристики BRCA1 5382insC/ СHEK2/BLM-ассоциированного рака молочной железы. Сибирский онкологический журнал. 2014; 6: 15–8. [Bit-Sava E.M. Hereditary charcteristics of BRCA1 5382insC/ SHEK2/BLM-associated breast cancer. Sibirskiy Onkologicheskiy Zhurnal (Siberian Journal of Oncology, Russian journal). 2014; 6: 15–8 (in Russ.).]
27. Tabar L., Tot T., Peter B.D. Breast cancer: early detection with mammography. Casting type calcifications: Sing of subtype with depictive features. Stuttgart: Thieme International; 2007.
28. Turnbull L., Brown S., Harvey I. et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomized controlled trial. Lancet. 2010; 375: 563–71.
29. Houssami N., Ciatto S., Macaskill P. et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: a systematic review and meta-analysis in detection of multifocal and multicentric cancer. J. Clin. Oncol. 2008; 26: 3248–58.
30. Houssami N., Turner R., Macaskill P. et al. An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J. Clin. Oncol. 2014; 32: 392–401.
31. Houssami N., Turner R., Morrow M. Preoperative magnetic resonance imaging in breast cancer: Metaanalysis of surgical outcomes. Ann. Surg. 2013; 257: 249–55.
32. Early Breast Cancer Trialists Collaborative Group. Effect of radiotherapy after breast concerving surgery on 10-year reccurence and 15-year breast cancer death: meta-analysis of individual patient data for 10.801 women in 17 randomized trails. Lancet. 2011; 378 (9804): 1707–16.
33. Early Breast Cancer Trialists Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365: 1687–717.
34. Yang T.J., Ho A.Y. Radiation therapy in management of breast cancer. Surg. Clin. North Am. 2013; 93 (2): 455–71.
35. Behjatnia B., Sim J., Bassett L.W. et al. Does size matter? Comparison study between MRI, gross, and microscopic tumor sizes in breast cancer in lumpectomy specimens. Int. J. Clin. Exp. Pathol. 2010; 3: 303–9.
36. Onesti J.K., Mangus B.E., Helmer S.D. et al. Breast cancer tumor size: Correlation between magnetic resonance imaging and pathology measurements. Am. J. Surg. 2008; 196: 844–50.
37. Mann R.M., Kuhl C.K., Kinkel K. et al. Breast MRI: guidelines from the European Society of Breast Imaging. Eur. Radiol. 2008; 6: 1307–18.
38. Lee Tucker F. Imaging-assisted large-format breast pathology: Program Rationale and Development in a Nonprofit Health System in the United States. 2012; 2012, Article ID 171792: 16.
39. Tabár L., Dean P.B., Lindhe N., Ingvarsson M. The ongoing revolution in breast imaging calls for a similar revolution in breast pathology. Int. J. Breast Cancer. 2012; 2012: 489345. DOI: 10.1155/2012/489345. Epub 2012 Sep 30.
Рецензия
Для цитирования:
Пучкова О.С., Синицын В.Е., Мершина Е.А. РОЛЬ МАГНИТНО-РЕЗОНАНСНОЙ ТОМОГРАФИИ МОЛОЧНЫХ ЖЕЛЕЗ В ПЛАНИРОВАНИИ ОРГАНОСОХРАНЯЮЩИХ ОПЕРАЦИЙ ПРИ РАКЕ МОЛОЧНОЙ ЖЕЛЕЗЫ. Вестник рентгенологии и радиологии. 2016;97(6):373-381. https://doi.org/10.20862/0042-4676-2016-97-6-373-381
For citation:
Puchkova O.S., Sinitsyn V.E., Mershina E.A. THE ROLE OF PREOPERATIVE BREAST MAGNETIC RESONANCE IMAGING IN PLANNING OF OPTIMUM SURGICAL TREATMENT FOR BREAST CANCER PATIENTS. Journal of radiology and nuclear medicine. 2016;97(6):373-381. (In Russ.) https://doi.org/10.20862/0042-4676-2016-97-6-373-381
Просмотров: 2638
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial» («Атрибуция — Некоммерческое использование») 3.0 Непортированная
Послать статью по эл. почте 